Suzanne Ostrand-Rosenberg, Professor Emerita, has joined the BriaCell Scientific Advisor Board. BriaCell is a a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers.
myUMBC is a UMBC limited public community forum for information sharing and dialogue. As a public institution, UMBC generally may not limit a community member's right to free speech on this forum. UMBC does not endorse the views expressed or information presented here, unless specifically stated in an official UMBC post. Learn more...